Questcor Pharmaceuticals acquired the rights to Doral from MedPointe

May. 2006

Client: Questcor Pharmaceuticals is a leading specialty / rare disease pharmaceutical company. Its lead product is Acthar Gel.

Role: Edgemont Partners acted as exclusive financial advisor to Questcor Pharmaceuticals in its acquisition of Doral from Medpointe Pharmaceuticals

Location: Hayward, CA

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release

questcor pharmaceuticals logo

acquired the rights to Doral from

medpointe logo
Get In Touch